Clinical use of whole genome sequencing for Mycobacterium tuberculosis
2016 · BMC Medicine · 113 citations
https://doi.org/10.1186/s12916-016-0598-2
A
Adam A. Witney
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
109
Papers
6.3K
Citations
37
h-index
61
i10-index
Adam A. Witney is an academic researcher from St George's, University of London. The author has contributed to research in topics: Tuberculosis Research and Epidemiology & Mycobacterium research and diagnosis & SARS-CoV-2 and COVID-19 Research. The author has an h-index of 37, co-authored 93 publications.
ORCID: 0000-0003-4561-7170Papers by this author
worksGuanylyl Cyclase Activity Associated with Putative Bifunctional Integral Membrane Proteins in Plasmodium falciparum
2000 · Journal of Biological Chemistry · 94 citations
https://doi.org/10.1074/jbc.m001021200
Use of whole-genome sequencing to distinguish relapse from reinfection in a completed tuberculosis clinical trial
2017 · BMC Medicine · 59 citations
https://doi.org/10.1186/s12916-017-0834-4
Baseline and acquired resistance to bedaquiline, linezolid and pretomanid, and impact on treatment outcomes in four tuberculosis clinical trials containing pretomanid
2023 · PLOS Global Public Health · 57 citations
https://doi.org/10.1371/journal.pgph.0002283
Publisher Correction: SARS-CoV-2 Omicron is an immune escape variant with an altered cell entry pathway
2022 · Nature Microbiology · 24 citations
https://doi.org/10.1038/s41564-022-01241-6
Genetic variation in Mycobacterium tuberculosis isolates from a London outbreak associated with isoniazid resistance
2016 · BMC Medicine · 17 citations
https://doi.org/10.1186/s12916-016-0659-6
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat